Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

iMDK, Tocris™

Suppresses endogenous midkine (MDK) expression in H441 lung adenocarcinoma cells. Suppresses tumor growth and induces cell death by inhibiting the PI 3-kinase pathway and inducing apoptosis in a mouse model derived from H441 lung adenocarcinoma cells

Manufacturer:  R&D Systems 5126/50

Quantity 50mg

 View more versions of this product

Catalog No. 51-265-0


  Check Availability
Add to cart

Specifications Description & Specifications

Chemical Identifiers

881970-80-5
376.4
iMDK
C21H13FN2O2S
3-[2-[(4-Fluorophenyl)methyl]imidazo[2, 1-b]thiazol-6-yl]-2H-1-benzopyran-2-one

Specifications

881970-80-5
376.4
50mg
C21H13FN2O2S
3-[2-[(4-Fluorophenyl)methyl]imidazo[2, 1-b]thiazol-6-yl]-2H-1-benzopyran-2-one
iMDK

Safety and Handling

Recommended Storage : Store at +4°C

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit